Dauricine interferes with SARS-CoV-2 variants infection by blocking the interface between RBD and ACE2
Description
The continued viral evolution results in the emergence of various SARS-CoV-2 variants, such as delta or omicron, that are partially resistant to current vaccines and antiviral medicines, posing an increased risk to global public health and raising
